UBS Group AG - MEDGENICS INC ownership

MEDGENICS INC's ticker is MDGN and the CUSIP is 58436Q203. A total of 56 filers reported holding MEDGENICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MEDGENICS INC
ValueSharesWeighting
Q3 2016$27,000
+170.0%
4,726
+170.1%
0.00%
Q2 2016$10,000
+25.0%
1,7500.0%0.00%
Q1 2016$8,000
-65.2%
1,750
-52.9%
0.00%
Q4 2015$23,0000.0%3,713
+25.9%
0.00%
Q3 2015$23,000
+27.8%
2,9500.0%0.00%
Q2 2015$18,000
-82.0%
2,950
-76.2%
0.00%
Q1 2015$100,000
+9900.0%
12,405
+6102.5%
0.00%
Q4 2014$1,0002000.00%
Other shareholders
MEDGENICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 163,347$848,0000.66%
CARL DOMINO INC 20,134$104,0000.06%
WHITE PINE CAPITAL LLC 20,000$104,0000.04%
Perceptive Advisors 55,073$286,0000.03%
WFG Advisors, LP 20,000$104,0000.02%
HYMAN CHARLES D 14,500$75,0000.01%
Spark Investment Management LLC 13,500$70,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$415,0000.01%
Baillie Gifford 360,650$1,872,0000.00%
Janney Montgomery Scott LLC 32,673$169,573,0000.00%
View complete list of MEDGENICS INC shareholders